Clinical trials
Phase 4 Multiple Sclerosis, Relapsing-Remitting trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
81 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 5 |
| 2004 | 5 |
| 2005 | 3 |
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 2 |
| 2009 | 3 |
| 2010 | 4 |
| 2011 | 7 |
| 2012 | 6 |
| 2013 | 3 |
| 2014 | 8 |
| 2015 | 7 |
| 2016 | 4 |
| 2017 | 6 |
| 2019 | 3 |
| 2020 | 3 |
| 2021 | 1 |
| 2022 | 3 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 45 |
| Terminated | 13 |
| Unknown status | 9 |
| Withdrawn | 7 |
| Recruiting | 3 |
| Active, not recruiting | 3 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Biogen | 21 |
| Novartis Pharmaceuticals | 15 |
| Tehran University of Medical Sciences | 5 |
| Merck KGaA, Darmstadt, Germany | 4 |
| Bayer | 3 |
| EMD Serono | 3 |
| Teva Branded Pharmaceutical Products R&D, Inc. | 3 |
| University Hospital Muenster | 3 |
| Amsterdam UMC, location VUmc | 2 |
| Claudio Gobbi | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Multiple Sclerosis, Relapsing-Remitting | 81 |
| Multiple Sclerosis | 33 |
| Anxiety Disorders | 1 |
| Erythema | 1 |
| Flushing | 1 |
| Injection Site Reaction | 1 |
| Memory Disorders | 1 |
| Neurobehavioral Manifestations | 1 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 |
| Recurrence | 1 |
Trials
Showing 1 to 25 of 81. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.